The first single view of the risk and return of the R&D landscape
Track and analyse clinical trials in the commercial context with ClinicalTrials.gov, EudraCT and a Japan clinical trials data source aggregated, standardised and integrated.
Identify and track future critical events and market catalysts for product lifecycles. Track key events, including Phase II and III trial initiation, completion and results, financial results, product filings and approvals, and expected generic competition.
Access NPV discounted cash flow models for over 4,500 products. Interactive, fully transparent models let you edit key assumptions – annual and peak sales, patent expiry date, cost of capital and tax rate – to create a custom model.
“ EvaluatePharma Vision is one of the most robust offerings for commercial sales data, probability of success and time-in-phase data in a single platform. We recently completed an R&D forecasting project and couldn’t have done the work without it. ”
“ EvaluatePharma Vision is outstanding. The amount of information they make available is amazing, and I have really come to understand the benefit of using it over competing products. ”